ERBB2 and lung carcinoma: Recent studies have shown that the signal of focal adhesion is decreased in tumors of patients with lung recurrence,30, 32, 33 while up to 75.8% of all lung cancer patients with first distant metastases have EGFR‐positive or HER2‐positive.